BioSpace News Archive

Biotech Beach

Persephone Biosciences Closes $15M Seed Financing Round

Persephone Biosciences Inc., a synthetic biology company reimagining patient and infant health through the development of microbiome-based medicines, today announced that it has closed a $15 million seed financing round.

July 19, 2022
·
3 min read
Business

Hansa Biopharma half year report 2022

Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and interim report for January to June 2022.

July 19, 2022
·
9 min read
Genetown

CN Bio Opens New Laboratory Facilities to Extend Organ-on-a-chip Contract Research Services Capabilities

CN Bio, a leading Organ-on-a-chip Company that designs and manufactures single-and multi-organ microphysiological systems, announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services.

July 19, 2022
·
2 min read
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Universe Pharmaceuticals INC announced that the Company received a written notification from the Nasdaq Stock Market LLC on July 15, 2022, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.

July 19, 2022
·
3 min read
STALICLA Awarded EUR 1.7 Million to Lead Computational Drug Repositioning Activities in EU-funded REPO4EU Project

REPO4EU consortium seeks to address the urgent need for new cost-effective therapies, as well as to improve existing treatments through international cooperation, pooling research and innovation expertise.

July 19, 2022
·
2 min read
Seegene launches world’s first In-life PCR campaign in Vietnam

Seegene Inc., South Korea’s leading molecular diagnostics company, will work with test center, LabHouse, to launch its In-life PCR campaign in Vietnam, for drivers of ride-hailing service Grab, starting August.

July 19, 2022
·
2 min read
Business

Johnson & Johnson Reports Q2 2022 Results

Johnson & Johnson announced results for second-quarter 2022. “Our solid second quarter results across Johnson & Johnson reflect the strength and resilience of our Company’s market leadership in the midst of macroeconomic challenges,” said Joaquin Duato, Chief Executive Officer.

July 19, 2022
·
12 min read
Business

Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer

Entrada Therapeutics, Inc. today announced the appointment of Karla MacDonald as Chief Corporate Affairs Officer, effective immediately.

July 19, 2022
·
3 min read
Pharm Country

Synchron Announces First Human U.S. Brain-Computer Interface Implant

Synchron , an endovascular brain-computer interface (BCI) company, today announced the first human BCI implant in the United States.

July 19, 2022
·
5 min read
Business

Sonendo, Inc. to Report Second Quarter 2022 Financial Results on August 10, 2022

Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, August 10, 2022.

July 19, 2022
·
2 min read